ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

USound Introduces Groundbreaking Innovation Enabling State-Of-The-Art Health Monitoring in TWS Earphones Without Additional Hardware

USound MEMS speakers have unlocked a new feature for true wireless systems (TWS) earphones, enabling the production of state-of-the-art health monitoring devices with no additional components.

USound, the global leader in Micro Electronic Mechanical Systems (MEMS) speakers, today announced a breakthrough that enables true wireless systems (TWS) earphones to feature advanced health monitoring without requiring additional components.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122983920/en/

USound MEMS speakers have unlocked a new feature for TWS earphones. (Photo: Business Wire)

USound MEMS speakers have unlocked a new feature for TWS earphones. (Photo: Business Wire)

“USound’s APG technology represents a transformative leap for in-ear devices”, stated Ferruccio Bottoni, USound’s CEO & Co-founder. “This new development revolutionizes the TWS industry, offering product developers the ability to enable state-of-the-art vital signs detection features without the need to integrate additional components. In the near future, users will enjoy Hi-Res audio and precise vital signs detection at the same time; a development that revolutionizes both the in-ear audio and health monitoring markets.”

In-ear vital signs detection

At the core of this breakthrough is USound’s Audioplethysmography (APG) technology, which uses special signals emitted by MEMS speakers to monitor vital signs such as heart rate. Unlike traditional optical methods, APG leverages existing in-ear device components, eliminating the need for additional hardware.

USound's APG technology is engineered to integrate effortlessly with its range of standalone MEMS speakers, as well as its two-way audio modules, co-developed with either OBO.Pro.2 or Luxshare-ICT. This flexibility allows product developers to integrate cutting-edge health monitoring features into their devices, whether leveraging standalone or modular designs.

Traditional TWS devices with active noise cancellation (ANC) already include inward-facing microphones. USound’s solution builds on this existing infrastructure by pairing its MEMS speakers with proprietary algorithms. These speakers emit audio and not audible signals, enabling simultaneous Hi-Res audio playback and health monitoring without compromising audio quality.

A Gateway to the Future of Health Monitoring

The results of APG testing so far have shown extreme precision, comparable to industry-standard ECG devices used in sports applications. An in-ear prototype of this technology is under development and will be available for testing by mid-2025.

“USound’s APG technology currently enables precise heart rate monitoring. Future developments aim to expand its capabilities to include metrics like respiration rate, heart rate variability, and blood oxygen saturation. These advancements will open new possibilities in fitness tracking, health monitoring, and medical diagnostics, reinforcing USound’s position as a leader in innovative audio and health solutions,” concluded Mr. Bottoni.

About USound

USound is a fast-growing MEMS speaker company that enables its customers to bring new revolutionary audio products to the market. USound’s unique selling proposition is based on radical miniaturization, power reduction, and increased production efficiency. Learn more by visiting www.usound.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.